Iron stores, hepcidin, and aortic stiffness in individuals with hypertension

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Valenti, Luca ^a   Maloberti, Alessandro ^b   Signorini, Stefano ^c   Milano, Marta ^a   Cesana, Francesca ^b   Cappellini, Fabrizio ^c   Dongiovanni, Paola ^a   Porzio, Marianna ^a   Soriano, Francesco ^b   Brambilla, Maura ^c   Cesana, Giancarlo ^d   Brambilla, Paolo ^c   Giannattasio, Cristina ^b   Fargion, Silvia ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

^c DESIO HOSPITAL   (Italy)

^d UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; HEPCIDIN; IRON;

ADULT; AGED; ARTERIAL STIFFNESS; ARTICLE; BODY MASS; CAROTID ARTERY PULSE; COHORT ANALYSIS; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; FEMALE; GENE MUTATION; HEART EJECTION FRACTION; HEART RATE; HEMOCHROMATOSIS; HORMONE BLOOD LEVEL; HUMAN; HYPERFERRITINEMIA; HYPERTENSION; IRON OVERLOAD; IRON STORAGE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PEAK SYSTOLIC VELOCITY; SYSTOLIC BLOOD PRESSURE; AORTA; BLOOD; MIDDLE AGED; PATHOPHYSIOLOGY; PULSE WAVE;

ADULT; AGED; AORTA; FEMALE; FERRITINS; HEPCIDINS; HUMANS; HYPERTENSION; IRON; MALE; MIDDLE AGED; PULSE WAVE ANALYSIS; VASCULAR STIFFNESS;

EID: 84942354146     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0134635     Document Type: Article

References (35)

1. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med. 1999; 340(2):115-26. doi: 10.1056/NEJM199901143400207 PMID: 9887164.
2. Nilsson PM, Khalili P, Franklin SS. Blood pressure and pulse wave velocity as metrics for evaluating pathologic ageing of the cardiovascular system. Blood pressure. 2014; 23(1):17-30. doi: 10.3109/08037051.2013.796142 PMID: 23750722.
3. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001; 37(5):1236-41. PMID: 11358934.
4. Ben-Shlomo Y, Spears M, Boustred C, May M, Anderson SG, Benjamin EJ, et al. Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects. Journal of the American College of Cardiology. 2014; 63(7):636-46. doi: 10.1016/j.jacc.2013.09.063 PMID: 24239664.
5. Kelly RP, Tunin R, Kass DA. Effect of reduced aortic compliance on cardiac efficiency and contractile function of in situ canine left ventricle. Circ Res. 1992; 71(3):490-502. PMID: 1386792.
6. O'Rourke MF, Safar ME. Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension. 2005; 46(1):200-4. doi: 10.1161/01.HYP.0000168052.00426.65 PMID: 15911742.
7. Jain S, Khera R, Corrales-Medina VF, Townsend RR, Chirinos JA. "Inflammation and arterial stiffness in humans". Atherosclerosis. 2014; 237(2):381-90. doi: 10.1016/j.atherosclerosis.2014.09.011 PMID: 25463062.
8. Sullivan JL. Macrophage iron, hepcidin, and atherosclerotic plaque stability. Exp Biol Med (Maywood). 2007; 232(8):1014-20. 232/8/1014 [pii]. doi: 10.3181/0703-MR-54 PMID: 17720947.
9. Sullivan JL. Iron and the sex difference in heart disease risk. Lancet. 1981; 1(8233):1293-4. PMID: 6112609.
10. Dongiovanni P, Fracanzani AL, Fargion S, Valenti L. Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target. J Hepatol. 2011; 55(4):920-32. S0168-8278(11)00442-9 [pii]. doi: 10.1016/j.jhep.2011.05.008 PMID: 21718726.
11. Valenti L, Swinkels DW, Burdick L, Dongiovanni P, Tjalsma H, Motta BM, et al. Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease. Nutr Metab Cardiovasc Dis. 2011; 21:568-75. S0939-4753(10)00011-6 [pii]. doi: 10.1016/j.numecd.2010.01.003 PMID: 20392616.
12. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004; 306(5704):2090-3. 1104742 [pii]. doi: 10.1126/science.1104742 PMID: 15514116.
13. Muckenthaler MU. Fine tuning of hepcidin expression by positive and negative regulators. Cell Metab. 2008; 8(1):1-3. S1550-4131(08)00180-0 [pii]. doi: 10.1016/j.cmet.2008.06.009 PMID: 18590684.
14. Valenti L, Dongiovanni P, Motta BM, Swinkels DW, Bonara P, Rametta R, et al. Serum Hepcidin and Macrophage Iron Correlate With MCP-1 Release and Vascular Damage in Patients With Metabolic Syndrome Alterations. Arterioscler Thromb Vasc Biol. 2011; 31:683-90. ATVBAHA.110.214858 [pii]. doi: 10.1161/ATVBAHA.110.214858 PMID: 21183736.
15. Pagani A, Nai A, Corna G, Bosurgi L, Rovere-Querini P, Camaschella C, et al. Low hepcidin accounts for the proinflammatory status associated with iron deficiency. Blood. 2011; 118(3):736-46. doi: 10.1182/blood-2011-02-337212 PMID: 21628413.
16. Cesana F, Nava S, Menni C, Boffi L, Varrenti M, Meani P, et al. Does the 9p region affect arterial stiffness? Results from a cohort of hypertensive individuals. Blood pressure. 2013; 22(5):302-6. doi: 10.3109/08037051.2013.765627 PMID: 23445356.
17. Reference Values for Arterial Stiffness C. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'establishing normal and reference values'. Eur Heart J. 2010; 31(19):2338-50. doi: 10.1093/eurheartj/ehq165 PMID: 20530030; PubMed Central PMCID: PMC2948201.
18. Maloberti A, Meani P, Varrenti M, Giupponi L, Stucchi M, Vallerio P, et al. Structural and Functional Abnormalities of Carotid Artery and Their Relation with EVA Phenomenon. High Blood Press Cardiovasc Prev. 2015. doi: 10.1007/s40292-015-0100-9 PMID: 25986075.
19. Valenti L, Canavesi E, Galmozzi E, Dongiovanni P, Rametta R, Maggioni P, et al. Beta-globin mutations are associated with parenchymal siderosis and fibrosis in patients with non-alcoholic fatty liver disease. J Hepatol. 2010; 53:927-33. S0168-8278(10)00627-6 [pii]. doi: 10.1016/j.jhep.2010.05.023 PMID: 20739079.
20. Adams PC, Reboussin DM, Barton JC, McLaren CE, Eckfeldt JH, McLaren GD, et al. Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med. 2005; 352(17):1769-78. PMID: 15858186.
21. Piperno A, Trombini P, Gelosa M, Mauri V, Pecci V, Vergani A, et al. Increased serum ferritin is common in men with essential hypertension. Journal of hypertension. 2002; 20(8):1513-8. PMID: 12172312.
22. Failla M, Giannattasio C, Piperno A, Vergani A, Grappiolo A, Gentile G, et al. Radial artery wall alterations in genetic hemochromatosis before and after iron depletion therapy. Hepatology. 2000; 32(3):569-73. doi: 10.1053/jhep.2000.16265 PMID: 10960451.
23. Valenti L, Conte D, Piperno A, Dongiovanni P, Fracanzani AL, Fraquelli M, et al. The mitochondrial superoxide dismutase A16V polymorphism in the cardiomyopathy associated with hereditary haemochromatosis. J Med Genet. 2004; 41(12):946-50. PMID: 15591282.
24. Winner MW 3rd, Sharkey-Toppen T, Zhang X, Pennell ML, Simonetti OP, Zweier JL, et al. Iron and noncontrast magnetic resonance T2∗ as a marker of intraplaque iron in human atherosclerosis. Journal of vascular surgery. 2014. doi: 10.1016/j.jvs.2014.02.006 PMID: 24674272; PubMed Central PMCID: PMC4175307.
25. Bories G, Colin S, Vanhoutte J, Derudas B, Copin C, Fanchon M, et al. Liver X receptor activation stimulates iron export in human alternative macrophages. Circ Res. 2013; 113(11):1196-205. doi: 10.1161/CIRCRESAHA.113.301656 PMID: 24036496; PubMed Central PMCID: PMC3989231.
26. Finn AV, Nakano M, Polavarapu R, Karmali V, Saeed O, Zhao X, et al. Hemoglobin directs macrophage differentiation and prevents foam cell formation in human atherosclerotic plaques. Journal of the American College of Cardiology. 2012; 59(2):166-77. doi: 10.1016/j.jacc.2011.10.852 PMID: 22154776; PubMed Central PMCID: PMC3253238.
27. Galesloot TE, Holewijn S, Kiemeney LA, de Graaf J, Vermeulen SH, Swinkels DW. Serum hepcidin is associated with presence of plaque in postmenopausal women of a general population. Arterioscler Thromb Vasc Biol. 2014; 34(2):446-56. doi: 10.1161/ATVBAHA.113.302381 PMID: 24334869.
28. Saeed O, Otsuka F, Polavarapu R, Karmali V, Weiss D, Davis T, et al. Pharmacological suppression of hepcidin increases macrophage cholesterol efflux and reduces foam cell formation and atherosclerosis. Arterioscler Thromb Vasc Biol. 2012; 32(2):299-307. ATVBAHA.111.240101 [pii]. doi: 10.1161/ATVBAHA.111.240101 PMID: 22095982.
29. van der Weerd NC, Grooteman MP, Bots ML, van den Dorpel MA, den Hoedt CH, Mazairac AH, et al. Hepcidin-25 is related to cardiovascular events in chronic haemodialysis patients. Nephrol Dial Transplant. 2012. gfs488 [pii]. doi: 10.1093/ndt/gfs488 PMID: 23147161.
30. Kuragano T, Itoh K, Shimonaka Y, Kida A, Furuta M, Kitamura R, et al. Hepcidin as well as TNF-{alpha} are significant predictors of arterial stiffness in patients on maintenance hemodialysis. Nephrol Dial Transplant. 2011. gfq760 [pii]. doi: 10.1093/ndt/gfq760 PMID: 21245128.
31. Canavesi E, Alfieri C, Pelusi S, Valenti L. Hepcidin and HFE protein: Iron metabolism as a target for the anemia of chronic kidney disease? World J Nephrol. 2012; 1:166-76. doi: 10.5527/wjn.v1.i6.166 PMID: 24175256
32. Wang H, Li H, Jiang X, Shi W, Shen Z, Li M. Hepcidin is directly regulated by insulin and plays an important role in iron overload in streptozotocin-induced diabetic rats. Diabetes. 2014; 63(5):1506-18. doi: 10.2337/db13-1195 PMID: 24379355.
33. Pichler G, Martinez F, Vicente A, Solaz E, Calaforra O, Lurbe E, et al. Influence of obesity in central blood pressure. Journal of hypertension. 2015; 33(2):308-13. PMID: 25380157.
34. Mozos I, Filimon L, Gligor S. Body mass index, blood pressure and arteriography variables in a middle and aged population. HealthMed. 2014; 8(4):442-50.
35. Mangoni AA, Giannattasio C, Brunani A, Failla M, Colombo M, Bolla G, et al. Radial artery compliance in young, obese, normotensive subjects. Hypertension. 1995; 26(6 Pt 1):984-8. PMID: 7490159.